AlphaCentric Advisors LLC acquires $1.16 million in Fulgent Genetics, Inc. (NASDAQ: FLGT)
AlphaCentric Advisors LLC has acquired a new stake in Fulgent Genetics, Inc. (Nasdaq: FLGT – Get the rating) in the third quarter, according to the latest 13F filing with the Securities and Exchange Commission. The fund acquired 30,500 shares of the company’s stock, with an estimated value of $1,163,000. Fulgent Genetics makes up 1.2% of … Read more